These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 23377880)
1. Endoscopic finding of spontaneous hemorrhage correlates with tumor necrosis factor alpha expression in colonic mucosa of patients with ulcerative colitis. Hozumi H; Hokari R; Kurihara C; Narimatsu K; Sato H; Sato S; Ueda T; Higashiyama M; Okada Y; Watanabe C; Komoto S; Tomita K; Kawaguchi A; Nagao S; Miura S Int J Colorectal Dis; 2013 Aug; 28(8):1049-55. PubMed ID: 23377880 [TBL] [Abstract][Full Text] [Related]
2. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease. Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752 [TBL] [Abstract][Full Text] [Related]
3. Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis. Tsukada Y; Nakamura T; Iimura M; Iizuka BE; Hayashi N Am J Gastroenterol; 2002 Nov; 97(11):2820-8. PubMed ID: 12425554 [TBL] [Abstract][Full Text] [Related]
4. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis. Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510 [TBL] [Abstract][Full Text] [Related]
5. Expression of IL-8, TNF-alpha and IFN-gamma m-RNA in ulcerative colitis, particularly in patients with inactive phase. Masuda H; Iwai S; Tanaka T; Hayakawa S J Clin Lab Immunol; 1995; 46(3):111-23. PubMed ID: 8926619 [TBL] [Abstract][Full Text] [Related]
7. Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis. Koch Hansen L; Sevelsted-Møller L; Rabjerg M; Larsen D; Hansen TP; Klinge L; Wulff H; Knudsen T; Kjeldsen J; Köhler R J Crohns Colitis; 2014 Nov; 8(11):1378-91. PubMed ID: 24793818 [TBL] [Abstract][Full Text] [Related]
8. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis. Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866 [TBL] [Abstract][Full Text] [Related]
9. Normalization of mucosal tumor necrosis factor-α: A new criterion for discontinuing infliximab therapy in ulcerative colitis. Olsen T; Rismo R; Gundersen MD; Paulssen EJ; Johnsen K; Kvamme JM; Goll R; Florholmen J Cytokine; 2016 Mar; 79():90-5. PubMed ID: 26775117 [TBL] [Abstract][Full Text] [Related]
10. Infliximab therapy decreases the levels of TNF-alpha and IFN-gamma mRNA in colonic mucosa of ulcerative colitis. Olsen T; Cui G; Goll R; Husebekk A; Florholmen J Scand J Gastroenterol; 2009; 44(6):727-35. PubMed ID: 19294580 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of mucosal suppressors of cytokine signaling 3 expression in ulcerative colitis. Miyanaka Y; Ueno Y; Tanaka S; Yoshioka K; Hatakeyama T; Shimamoto M; Sumii M; Chayama K World J Gastroenterol; 2007 Jun; 13(21):2939-44. PubMed ID: 17589943 [TBL] [Abstract][Full Text] [Related]
12. Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome. Raddatz D; Bockemühl M; Ramadori G Eur J Gastroenterol Hepatol; 2005 May; 17(5):547-57. PubMed ID: 15827446 [TBL] [Abstract][Full Text] [Related]
13. TNF-alpha gene expression in colorectal mucosa as a predictor of remission after induction therapy with infliximab in ulcerative colitis. Olsen T; Goll R; Cui G; Christiansen I; Florholmen J Cytokine; 2009 May; 46(2):222-7. PubMed ID: 19286392 [TBL] [Abstract][Full Text] [Related]
14. Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis. Rismo R; Olsen T; Cui G; Christiansen I; Florholmen J; Goll R Scand J Gastroenterol; 2012 May; 47(5):538-47. PubMed ID: 22486187 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis. Dubois-Camacho K; Diaz-Jimenez D; De la Fuente M; Quera R; Simian D; Martínez M; Landskron G; Olivares-Morales M; Cidlowski JA; Xu X; Gao G; Xie J; Chnaiderman J; Soto-Rifo R; González MJ; Calixto A; Hermoso MA Front Immunol; 2019; 10():2449. PubMed ID: 31824476 [TBL] [Abstract][Full Text] [Related]
16. Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis. Ishiguro Y J Gastroenterol; 1999 Feb; 34(1):66-74. PubMed ID: 10204613 [TBL] [Abstract][Full Text] [Related]
17. Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis. Melgar S; Yeung MM; Bas A; Forsberg G; Suhr O; Oberg A; Hammarstrom S; Danielsson A; Hammarstrom ML Clin Exp Immunol; 2003 Oct; 134(1):127-37. PubMed ID: 12974765 [TBL] [Abstract][Full Text] [Related]
18. KFL2 participates in the development of ulcerative colitis through inhibiting inflammation via regulating cytokines. Wang ZL; Wang YD; Wang K; Li JA; Li L Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4941-4948. PubMed ID: 30070340 [TBL] [Abstract][Full Text] [Related]
19. Global mucosal and serum cytokine profile in patients with ulcerative colitis undergoing anti-TNF therapy. Dahlén R; Magnusson MK; Bajor A; Lasson A; Ung KA; Strid H; Öhman L Scand J Gastroenterol; 2015; 50(9):1118-26. PubMed ID: 25877762 [TBL] [Abstract][Full Text] [Related]